TissGeneSummary for C11orf85 |
Gene summary |
Basic gene information | Gene symbol | C11orf85 |
Gene name | chromosome 11 open reading frame 85 | |
Synonyms | - | |
Cytomap | UCSC genome browser: 11q13.1 | |
Type of gene | protein-coding | |
RefGenes | NM_001037225.2, NM_001300803.1, | |
Description | uncharacterized protein C11orf85 | |
Modification date | 20141207 | |
dbXrefs | HGNC : HGNC | |
Ensembl : ENSG00000168070 | ||
HPRD : 18761 | ||
Vega : OTTHUMG00000165632 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_C11orf85 | |
BioGPS: 283129 | ||
Pathway | NCI Pathway Interaction Database: C11orf85 | |
KEGG: C11orf85 | ||
REACTOME: C11orf85 | ||
Pathway Commons: C11orf85 | ||
Context | iHOP: C11orf85 | |
ligand binding site mutation search in PubMed: C11orf85 | ||
UCL Cancer Institute: C11orf85 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | HPA,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Testis | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | TGCT | |
Reference showing the relevant tissue of C11orf85 | ||
Description by TissGene annotations |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for C11orf85 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
KICH | -2.581594433 | -0.050454433 | -2.53114 | 3.26E-11 | 2.81E-10 |
LUAD | -0.933562157 | -2.234763881 | 1.301201724 | 7.66E-06 | 2.28E-05 |
Top |
TissGene-miRNA for C11orf85 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for C11orf85 |
TissGeneSNV for C11orf85 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.M107I | SKCM | 1 |
p.E193K | SKCM | 1 |
p.E122K | SKCM | 1 |
p.M139T | STAD | 1 |
p.G102R | SKCM | 1 |
p.R75M | LGG | 1 |
p.E6K | SKCM | 1 |
p.E122Q | ESCA | 1 |
p.E91D | UCEC | 1 |
p.S185N | ESCA | 1 |
p.N40T | SKCM | 1 |
p.K163N | STAD | 1 |
p.R108Q | SKCM | 1 |
p.T45A | UCEC | 1 |
p.S195Y | LUAD | 1 |
p.R206S | ESCA | 1 |
p.F87L | BLCA | 1 |
p.P5S | SKCM | 1 |
p.G160E | SKCM | 1 |
p.G30E | SARC | 1 |
p.H5Y | SARC | 1 |
p.P20S | SKCM | 1 |
p.I120V | BRCA | 1 |
p.N165S | UCEC | 1 |
p.L48M | UCEC | 1 |
p.V94G | BLCA | 1 |
p.R53C | LUAD | 1 |
p.E112K | SKCM | 1 |
p.S179A | BLCA | 1 |
Top |
TissGeneCNV for C11orf85 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for C11orf85 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | FusionScan | LGG | TCGA-HT-7686-01A | SNX15-C11orf85 | Out-of-Frame | chr11:64795108 | chr11:64708118 |
Chimerdb3.0 | FusionScan | BRCA | TCGA-EW-A1IW-01A | SDHAF2-C11orf85 | CDS-5'UTR | chr11:61205585 | chr11:64727609 |
Chimerdb3.0 | TopHat-Fusion | UCEC | TCGA-D1-A3DH-01A | C11orf85-DPF2 | 5'UTR-CDS | chr11:64726950 | chr11:65113829 |
Chimerdb3.0 | TopHat-Fusion | LGG | TCGA-HT-7686-01A | SNX15-C11orf85 | Out-of-Frame | chr11:64795107 | chr11:64708117 |
TCGAfusionPortal | PRADA | BRCA | TCGA-EW-A1IW-01A | SDHAF2-C11orf85 | CDS-5UTR | Chr11:61205585 | Chr11:64727607 |
TCGAfusionPortal | PRADA | LGG | TCGA-HT-7686-01A | SNX15-C11orf85 | Out-of-frame | Chr11:64795108 | Chr11:64708118 |
Top |
TissGeneNet for C11orf85 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for C11orf85 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for C11orf85 |
TissGeneDrug for C11orf85 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for C11orf85 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |